C3a and C5a Are Chemotaxins for Human Mast Cells and Act Through Distinct Receptors via a Pertussis Toxin-Sensitive Signal Transduction Pathway

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1693-1698

  Nilsson, Gunnar ^a,b,c   Johnell, Matilda ^a   Hammer, Carl H ^b   Tiffany, H Lee ^b   Nilsson, Kenneth ^a   Metcalfe, Dean D ^b   Siegbahn, Agneta ^a   Murphy, Philip M ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BORDETELLA VIRULENCE FACTOR; CHEMOTACTIC FACTOR; COMPLEMENT C3A RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PERTUSSIS TOXIN; RECOMBINANT PROTEIN; STEM CELL FACTOR;

ARTICLE; CELL CULTURE; DRUG EFFECT; HUMAN; MAST CELL; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C3A; COMPLEMENT C5A; GTP-BINDING PROTEINS; HUMANS; MAST CELLS; MEMBRANE PROTEINS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PERTUSSIS TOXIN; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STEM CELL FACTOR; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0030586621     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Nilsson, G., and L. B. Schwartz. 1994. Mast cell heterogeneity: structure and mediators. In Mechanisms in Asthma and Rhinitis. W. W. Busse, and S. T. Holgate, eds. Blackwell Scientific Publications, Boston, p. 195.
2. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1993. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147:697.
3. Enerbäck, L., U. Pipkorn, and G. Granerus. 1986. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int. Arch. Allergy Appl. Immunol. 80:44.
4. Hawkins, R. A., H. N. Claman, R. A. Clark, and J. C. Steigerwald. 1985. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. 102:182.
5. Chanez, P., J. Y. Lacoste, B. Guillot, J. Giron, G. Barneon, I. Enander, P. Godard, F. B. Michel, and J. Bousquet. 1993. Mast cells' contribution to the fibrosing alveolilis of the scleroderma lung. Am. Rev. Respir. Dis. 147:1497.
6. Wasserman, S. I. 1987. The mast cell and synovial inflammation: or, what's a nice cell like you doing in a joint like this. Arthritis Rheum. 27:841.
7. Aldenborg, F., M. Fall, and L. Enerbäck. 1986. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystis. Immunology 58:411.
8. Li, Q., A. A. Raza, M. A. MacAulay, L. D. Lalonde, G. Rowden, E. Trethewey, and S. Dean. 1992. The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation 53:1047.
9. Irani, A. A., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009.
10. Valent, P., E. Spanblöchl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237.
11. Meininger, C. J., H. Yano, R. Rottapel, A. Bernstein, K. M. Zsebo, and B. R. Zetter. 1992. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958.
12. Nilsson, G., J. H. Butterfield, K. Nilsson, and A. Siegbahn. 1994. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 153:3717.
13. Gruber, B. L., M. J. Marchese, and R. R. Kew. 1994. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J. Immunol. 152:5860.
14. Johnson, A. R., T. E. Hugli, and H. J. Müller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28:1067.
15. El-Lati, S. G., C. A. Dahinden, and M. K. Church. 1994. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102:803.
16. Butterfield, J. H., D. Weiler, G. Dewald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:345.
17. Nilsson, G., T. Blom, G. M. Kusche, L. Kjellén, J. H. Butterfield, C. Sundström, K. Nilsson, and L. Hellman. 1994. Phenotypic characterization of the human mast cell line HMC-1. Scand. J. Immunol. 39:489.
18. Gallagher, R., S. Collins, J. Trujillo, M. McCredie, M. Ahearn, S. Tsai, R. Metzgar, G. Aulakh, R. Ting, F. Ruscetti, and R. Gallo. 1979. Characterization of the continous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713.
19. Sundström, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:565.
20. Gao, J.-L., E. L. Becker, R. J. Freer, N. Muthukumaraswamy, and P. M. Murphy. 1994. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J. Exp. Med. 180:2191.
21. Siegbahn, A., A. Hammacher, B. Westermark, and C. H. Heldin. 1990. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblast, monocytes, and granulocytes. J. Clin. Invest. 85:916.
22. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis. J. Exp. Med. 137:387.
23. Renfer, L., M. M. Frank, C. H. Hammer, L. Harvath, T. J. Lawley, and K. B. Yancey. 1986. A simplified method for purification of human C5a from citrated plasma. J. Immunol. Methods 88:193.
24. Hugli, T. E. 1981. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. CRC Crit. Rev. Immunol. 2:321.
25. Fox, C. C., A. Kagey-Sobotka, R. P. Schleimer, S. P. Peters, D. W. MacGlashan, Jr., and L. M. Lichtenstein. 1985. Mediator release from human basophils and mast cells from lung and intestinal mucosa. Int. Arch. Allergy Appl. Immunol. 77:130.
26. Okuda, M., H. Ohtsuka, and S. Kawabori. 1983. Basophil leukocytes and mast cells in the nose. Eur. J. Respir. Dis. 64 (Suppl 128):7.
27. Fokkens, W. J., T. Godlhelp, A. F. Holm, H. Blom, P. G. Mulder, T. M. Vroom. and E. Rijntjes. 1992. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis an non-allergic control: a biopsy study. Clin. Exp. Allergy 22:701.
28. Mattoli, S., V. Ackerman, E. Vitiori, and M. Marini. 1995. Mast cell chemotactic activity of RANTES. Biochem. Biophys. Res. Commun. 209:316.
29. Matsuura, N., and B. R. Zetter. 1989. Stimulation of mast cell chemotaxis by interleukin-3. J. Exp. Med. 170:1421.
30. Taub, D., J. Dastych, N. Inamura, J. Upton, D. Kelvin, D. Metcalfe, and J. Oppenheim. 1995. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J. Immunol. 154:2393.
31. Gruber, B. L., M. J. Marchese, and R. Kew. 1995. Angiogenic factors stimulate mast-cell migration. Blood 86:2488.
32. Ghebrehiwet, B., R. R. Kew, B. L. Gruber, M. J. Marchese, E. Peerschke, and K. Reid. 1995. Murine mast cells express two types of Clq receptors that are involved in the induction of chemotaxis and chemokinesis. J. Immunol. 155:2614.
33. Müller-Eberhard, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321.
34. Callerame, M. L., J. J. Condemi, M. G. Bohrod, and J. H. Vaughan. 1971. Immunologic reactions of bronchial tissues in asthma. N. Engl. J. Med. 284:459.
35. van der Linden, P. W., C. E. Hack, J. A. Kerckhaert, A. Struyvenberg, and J. C. van der Zwan. 1990. Preliminary report: complement activation in wasp-sting anaphylaxis. Lancet 336:904.
36. Kapp, A., H. Wokalek, and E. Schopf. 1985. Involvement of complement in psoriasis and atopic dermatitis: measurement of C3a and C5a, C3, C4 and Cl inactivator. Arch. Dermatol Res. 277:359.
37. Kapp, A., S. Meske-Brand, F. E. Maly, and W. Muller. 1984. Complement activation in patients with cronic polyarthritis measured by the level of complement fraction C3a in plasma. Z. Rheumatol. 43:103.
38. Zilow, G., J. A. Sturm, U. Rother, and M. Kirschfink. 1990. Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin. Exp. Immunol. 79:151.
39. Daffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils: C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119.
40. Gerard, N. P., and C. Gerard. 1991. The chemotactic receptor for C5a anaphylatoxin. Nature 349:614.
41. Boulay, F. L., M. Mery, L. Tardif, L. Brouchon, and P. Vignais. 1991. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30:2993.
42. Schlossman, S. F., L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. L. Silverstein, T. A. Springer, T. F. Tedder, and R. F. Todd. 1994. CD antigens 1993. Immunol. Today 15:98.
43. Füreder, W., H. Agis, M. Willheim, H. C. Bankl, U. Maier, K. Kishi, M. R. Muller, K. Czerwenka, T. Radaszkiewicz, J. H. Butterfield, G. W. Klappacher, W. R. Sperr, M. Oppermann, K. Lechner, and P. Valent. 1995. Differential expression of complement receptors on human basophils and mast cells: evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155:3152.
44. Fukuoka, Y., and T. E. Hugh. 1988. Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140:3496.
45. Gerardy-Schahn, R., D. Ambrosius, D. Saunders, M. Casaretto, C. Mittler, C. Karwarth, S. Gorgen, and D. Bitter-Saerman. 1989. Characterization of a C3a receptor protein on guinea pig platelets and human polymorphonuclear leukocytes. Eur. J. Immunol. 19:1095.
46. Bischoff, S. C., A. L. de Weck, and C. Dahinden. 1991. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc. Natl. Natl. Sci. USA 87:6813.
47. 125I-C3a binding. Biochemistry 31:11274.
48. Kretzschmar, T., A. Jeromin, C. Gietz, W. Bautsch, A. Klos, J. Köhl, G. Rechkemmer, and S. D. Bitter. 1993. Chronic myclogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. Eur. J. Immunol. 23:558.
49. Mousli, M., T. E. Hugli, Y. Landry, and C. Bronner. 1992. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. Immunol. 148:2456.
50. Legler, D. F., M. Loctscher, S. A. Jones, C. A. Dahinden, M. Arock, and B. Moser. 1996. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26:753.